• Dasatinib Monohydrate in CML and NET Research

  2026-10-10

  Research on chronic myeloid leukemia links the disease state to increased neutrophil extracellular trap formation and suggests that tyrosine kinase inhibitors can affect this process differently. This overview places Dasatinib Monohydrate and BMS-354825 within that research context, separating published findings from supplier information and highlighting the limits of translating cell and model-system observations into conclusions about vascular toxicity or patient outcomes.

• Ibuprofen Synthesis: Advances, Evidence, and Limits

  2026-10-09

  Ha and Paek’s 2021 review maps major advances in ibuprofen and naproxen synthesis, with emphasis on practical route design, asymmetric methods, derivative discovery, and continuous-flow chemistry. Its main value is comparative: it shows how modern synthetic research addresses step economy, stereochemical control, scalability, and access to structurally modified NSAIDs without presenting a single universally superior route.

• SM-102 and Targeted mRNA Delivery: Evidence and Limits

  2026-10-09

  SM-102 is an ionizable lipid associated with lipid nanoparticle mRNA delivery, but the supplied lymph-node targeting study evaluated a different polyethyleneimine-based polyplex. This overview separates supplier-described properties from peer-reviewed findings, examines the study’s reported immune and tumor outcomes, and explains why its results cannot be directly attributed to SM-102 or generalized to clinical mRNA vaccine development.

• Ibuprofen: Evidence and Research Context

  2026-10-08

  A source-grounded overview of Ibuprofen and 2-[4-(2-methylpropyl)phenyl]propanoic acid, examining COX biology, reported anticancer and animal findings, conceptual applications, evidence strength, provenance, and limitations without treating promotional claims as established clinical evidence.

• Annexin V-HF647/PI Kit for ESCC Apoptosis Research

  2026-10-08

  The Annexin V-HF647/PI Apoptosis Kit provides a conceptually useful way to interpret apoptosis-associated membrane changes in ESCC models. This article connects dual-marker assay biology with the HOXC9–AKT/mTOR findings while clarifying what the method can—and cannot—establish about mitochondria-dependent cell death.

• 10058-F4 and the c-Myc–TERT Axis

  2026-10-07

  Explore how 10058-F4, a c-Myc-Max dimerization inhibitor, connects transcriptional control with TERT chromatin regulation. This evidence-focused analysis separates catalog claims from findings in a recent human stem-cell preprint and defines the compound’s interpretive boundaries.

• Cisplatin: DNA Damage, Resistance, and New Evidence

  2026-10-07

  Cisplatin and CDDP remain central to cancer research because DNA damage alone does not explain treatment response. This evidence-focused article examines how PRMT5-targeted co-delivery and tumor-microenvironment responsiveness may reshape interpretation of chemotherapy resistance studies.

• Ibuprofen Synthesis Advances: Evidence from a 2021 Review

  2026-10-06

  Ha and Paek’s 2021 review maps recent advances in ibuprofen and naproxen synthesis, emphasizing practical, asymmetric, derivative-oriented, and continuous-flow approaches. Its main contribution is comparative: it shows how route design has evolved beyond classical preparation toward improved step economy, stereochemical control, scalability, and access to structurally refined NSAID candidates.

• NPC1/USP7/p53 Axis in Liver Cancer

  2026-10-06

  A 2026 Oncogene study identifies NPC1 as a multifunctional driver of hepatocellular carcinoma, connecting lysosomal cholesterol handling with USP7-dependent p53 destabilization. Its integrated clinical, cellular, animal, and mechanistic evidence supports NPC1 as a candidate regulator of HCC proliferation, while leaving important questions about patient-level therapeutic relevance.

• Bufuralol Hydrochloride: Evidence and Scope

  2026-10-05

  A source-grounded overview of what human iPSC-derived intestinal organoids can—and cannot—show about Bufuralol hydrochloride, β-adrenergic pharmacology, metabolism, transport and translational interpretation.

• Sodium Chloride B7288: Product Overview

  2026-10-05

  Sodium chloride (NaCl; CAS 7647-14-5; molecular weight 58.44) is an inorganic salt listed by APExBIO as a laboratory reagent for conceptual use in aqueous buffer preparation, ionic strength regulation, and osmotic balance. No matched paper evidence is available, so application-specific performance and suitability are not established.

• Decitabine in Cancer Epigenetics: Evidence and Limits

  2026-10-04

  This overview examines Decitabine (5-Aza-2'-deoxycytidine) as a DNA methyltransferase inhibitor in hematopoietic malignancy research and solid tumor epigenetic studies. It connects the compound’s conceptual role in tumor suppressor gene reactivation with recent findings on Helicobacter pylori-associated HNF4A silencing in gastric cancer, while distinguishing reported evidence from hypotheses and outlining key translational limitations.

• Hexamethonium Bromide in Autonomic Research

  2026-10-03

  Hexamethonium Bromide is studied as a ganglionic nicotinic-receptor antagonist in research on autonomic regulation. This overview examines its conceptual relevance to angiotensin II-induced hypertension, summarizes findings from a conscious-mouse study, and distinguishes evidence about ganglionic blockade from evidence specific to the compound.

• Palbociclib (PD0332991) in Tumor Assays

  2026-10-02

  Use Palbociclib as a mechanistic CDK4/6 probe, not simply as a viability reagent. This workflow connects cell-cycle arrest, apoptosis readouts, and patient-matched gastric cancer assembloids to reveal how stromal context can reshape drug response.

• Machine Learning for Senolytic Discovery

  2026-10-01

  The reference study shows that cost-effective machine-learning models trained on published, heterogeneous screening data can identify previously unrecognized senolytic candidates. Experimental validation of ginkgetin, periplocin, and oleandrin demonstrates a practical route from sparse literature data to cell-based discovery while highlighting the importance of senescence model and cell-type context.

8603 records 1/574 page Next 12345 下5页 Last page